Drug target prediction using chem- and bioinformatics

References

[1] Rodrigues T. Harnessing the potential of natural products in drug discovery from a cheminformatics vantage point. Org Biomol Chem. 2017;15:9275–82.10.1039/C7OB02193CSearch in Google Scholar PubMed

[2] Rodrigues T, Reker D, Schneider P, Schneider G. Counting on natural products for drug design. Nat Chem. 2016;8:531–41.10.1038/nchem.2479Search in Google Scholar PubMed

[3] Mullard A. 2017 FDA drug approvals. Nat Rev Drug Discov. 2018;17:81–5.10.1038/nrd.2018.4Search in Google Scholar PubMed

[4] Reker D, Rodrigues T, Schneider P, Schneider G. Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus. Proc Natl Acad Sci USA. 2014;111:4067–72.10.1073/pnas.1320001111Search in Google Scholar PubMed PubMed Central

[5] Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008;4:682–90.10.1038/nchembio.118Search in Google Scholar PubMed

[6] Hopkins AL. Network pharmacology. Nat Biotechnol. 2007;25:1110–1.10.1038/nbt1007-1110Search in Google Scholar PubMed

[7] Maruca A, Ambrosio FA, Lupia A, Romeo I, Rocca R, Moraca F, et al. Computer-based techniques for lead identification and optimization I: Basics. Phys Sci Rev 2018. DOI: 10.1515/psr-2018-0113. Forthcoming.Search in Google Scholar

[8] Lupia A, Moraca F, Maruca A, Ambrosio FA, Catalano R, Romeo I, et al. Computer-based techniques for lead identification and optimization II: advanced search methods. Phys Sci Rev 2018. DOI: 10.1515/psr-2018-0114. Forthcoming.Search in Google Scholar

[9] Wetzel S, Bon RS, Kumar K, Waldmann H. Biology-oriented synthesis. Angew Chem Int Ed. 2011;50:10800–26.10.1002/anie.201007004Search in Google Scholar PubMed

[10] Van Hattum H, Waldmann H. Biology-oriented synthesis: harnessing the power of evolution. J Am Chem Soc. 2014;136:11853–9.10.1021/ja505861dSearch in Google Scholar PubMed

[11] Baran PS. Natural product total synthesis: as exciting as ever and here to stay. J Am Chem Soc. 2018;140:4751–5.10.1021/jacs.8b02266Search in Google Scholar PubMed

[12] Laraia L, Waldmann H. Natural product inspired compound collections: evolutionary principle, chemical synthesis, phenotypic screening, and target identification. Drug Discov Today Technol. 2017;23:75–82.10.1016/j.ddtec.2017.03.003Search in Google Scholar PubMed

[13] Parker CG, Kuttruff CG, Galmozzi A, Jorgensen L, Yen CH, Hermanson DJ, et al. Chemical proteomics identifies SLC25A20 as a functional target of the ingenol class of actinic keratosis drugs. ACS Cent Sci. 2017;3:1276–8510.1021/acscentsci.7b00420Search in Google Scholar PubMed

[14] Schneider G. Virtual screening: an endless staircase? Nat Rev Drug Discov. 2010;9:273–6.10.1038/nrd3139Search in Google Scholar PubMed

[15] Singh G, Schulthess D, Hughes N, Vannieuwenhuyse B, Kalra D. Real world big data for clinical research and drug development. Drug Discov Today. 2018;23:652–60.10.1016/j.drudis.2017.12.002Search in Google Scholar PubMed

[16] Lavecchia A. Machine-learning approaches in drug discovery: methods and applications. Drug Discov Today. 2015;20:318–31.10.1016/j.drudis.2014.10.012Search in Google Scholar PubMed

[17] Henkel T, Brunne RM, Muller H, Reichel F. Statistical investigation into the structural complementarity of natural products and synthetic compounds. Angew Chem Int Ed. 1999;38:643–7.10.1002/(SICI)1521-3773(19990301)38:5<643::AID-ANIE643>3.0.CO;2-GSearch in Google Scholar

[18] Stahura FL, Godden JW, Xue L, Bajorath J. Distinguishing between natural products and synthetic molecules by descriptor Shannon entropy analysis and binary QSAR calculations. J Chem Inf Comput Sci. 2000;40:1245–52.10.1021/ci0003303Search in Google Scholar PubMed

[19] Wermuth C-G, Ganellin CR, Lindberg P, Mitscher LA. Glossary of terms used in medicinal chemistry (IUPAC recommendations 1997). Annu Rep Med Chem. 1998;33:385–95.10.1016/S0065-7743(08)61101-XSearch in Google Scholar

[20] Seidel T, Ibis G, Bendix F, Wolber G. Strategies for 3D pharmacophore-based virtual screening. Drug Discov Today Technol. 2010;7:e203–70.10.1016/j.ddtec.2010.12.004Search in Google Scholar PubMed

[21] Langer T, Wolber G. Pharmacophore definition and 3D searches. Drug Discov Today Technol. 2004;1:203–7.10.1016/j.ddtec.2004.11.015Search in Google Scholar PubMed

[22] Schneider G, Schneider P, Renner S. Scaffold-hopping: how far can you jump? QSAR Comb Sci. 2006;25:1162–71.10.1002/qsar.200610091Search in Google Scholar

[23] Gasteiger J, Rudolph C, Sadowski J. Automatic generation of 3D-atomic coordinates for organic molecules. Tetrahedron Comput Method. 1990;3:536–47.10.1016/0898-5529(90)90156-3Search in Google Scholar

[24] Chen I-J, Foloppe N. Conformational sampling of drug like molecules with MOE and catalyst: implications for pharmacophore modeling and virtual screening. J Chem Inf Model. 2008;48:1773–91.10.1021/ci800130kSearch in Google Scholar PubMed

[25] Rupp M, Bauer MR, Wilcken R, Lange A, Reutlinger M, Boeckler FM, et al. Machine learning estimates of natural product conformational energies. PLoS Comput Biol. 2014;10:1003400.10.1371/journal.pcbi.1003400Search in Google Scholar PubMed PubMed Central

[26] Renner S, Schwab CH, Gasteiger J, Schneider G. Impact of conformational flexibility on three-dimensional similarity searching using correlation vectors. J Chem Inf Model. 2006;46:2324–32.10.1021/ci050075sSearch in Google Scholar PubMed

[27] Zhang Q, Muegge I. Scaffold hopping through virtual screening using 2D and 3D similarity descriptors: ranking, voting, and consensus scoring. J Med Chem. 2006;49:1536–48.10.1021/jm050468iSearch in Google Scholar PubMed

[28] Hawkins PC, Skillman AG, Nicholls A. Comparison of shapematching and docking as virtual screening tools. J Med Chem. 2007;50:74–82.10.1021/jm0603365Search in Google Scholar PubMed

[29] Sadowski J, Gasteiger J, Klebe G. Comparison of automatic threedimensional model builders using 639 X-ray structures. J Chem Inf Comput Sci. 1994;34:1000–8.10.1021/ci00020a039Search in Google Scholar

[30] Güner O, Clement O, Kurogi Y. Pharmacophore modeling and three dimensional database searching for drug design using catalyst: recent advances. Curr Med Chem. 2004;11:2991–3005.10.2174/0929867043364036Search in Google Scholar PubMed

[31] Molecular Operating Environment (MOE) 2012.10 (2012).Search in Google Scholar

[32] McGarrah DB, Judson RS. Analysis of the genetic algorithm method of molecular conformation determination. J Comput Chem. 1993;14:1385–95.10.1002/jcc.540141115Search in Google Scholar

[33] Saunders M. Stochastic exploration of molecular mechanics energy surfaces. Hunting for the global minimum. J Am Chem Soc. 1987;109:3150–2.10.1021/ja00244a051Search in Google Scholar

[34] Saunders M. Stochastic search for the conformations of bicyclic hydrocarbons. J Comput Chem. 1989;10:203–8.10.1002/jcc.540100207Search in Google Scholar

[35] Chang G, Guida WC, Still WC. An internal coordinate Monte Carlo method for searching conformational space. J Am Chem Soc. 1989;111:4379–86.10.1021/ja00194a035Search in Google Scholar

[36] Wolber G, Seidel T, Bendix F, Langer T. Molecule-pharmacophore superpositioning and pattern matching in computational drug design. Drug Discov Today. 2008;13:23–9.10.1016/j.drudis.2007.09.007Search in Google Scholar PubMed

[37] Catalyst, Accelrys Inc., http://accelrys.comSearch in Google Scholar

[38] Wolber G, Langer T. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening fi lters. J Chem Inf Model. 2005;45:160–9.10.1021/ci049885eSearch in Google Scholar PubMed

[39] Dixon SL, Smondyrev AM, Rao SR. PHASE: a novel approach to pharmacophore modeling and 3D database searching. Chem Biol Drug Des. 2006;67:370–2.10.1111/j.1747-0285.2006.00384.xSearch in Google Scholar PubMed

[40] Lower M, Geppert T, Schneider P, Hoy B, Wessler S, Schneider G. Inhibitors of helicobacter pylori protease HtrA found by ‘virtual ligand’ screening combat bacterial invasion of epithelia. PLoS One. 2011;6:1798610.1371/journal.pone.0017986Search in Google Scholar PubMed PubMed Central

[41] Rodrigues T, Moreira R, Gut J, Rosenthal PJ, O'Neill PM, Biagini GA, et al. Identification of new antimalarial leads by use of virtual screening against cytochrome bc1. Bioorg Med Chem. 2011;19:6302–810.1016/j.bmc.2011.09.004Search in Google Scholar PubMed

[42] Vuorinen A, Nashev LG, Odermatt A, Rollinger JM, Schuster D. Pharmacophore model refinement for 11beta-hydroxysteroid dehydrogenase inhibitors: search for modulators of intracellular glucocorticoid concentrations. Mol Inf. 2014;33:15–25.10.1002/minf.201300063Search in Google Scholar PubMed

[43] Bauer J, Waltenberger B, Noha SM, Schuster D, Rollinger JM, Boustie J, et al. Discovery of depsides and depsidones from lichen as potent inhibitors of microsomal prostaglandin E2 synthase-1 using pharmacophore models. ChemMedChem. 2012;7:2077–8110.1002/cmdc.201200345Search in Google Scholar PubMed

[44] Rollinger JM, Schuster D, Danzl B, Schwaiger S, Markt P, Schmidtke M, et al. In silico target fishing for rationalized ligand discovery exemplified on constituents of Ruta graveolens. Planta Med. 2009;75:195–20410.1055/s-0028-1088397Search in Google Scholar PubMed

[45] Fakhrudin N, Ladurner A, Atanasov AG, Heiss EH, Baumgarter L, Markt P, et al. Computer-aided discovery, validation, and mechanistic characterization of novel neolignan activators of peroxisome proliferator-activated receptor gamma. Mol Pharmacol. 2010;77:559–6610.1124/mol.109.062141Search in Google Scholar PubMed

[46] Atanasov AG, Wang JN, Gu SP, Bu J, Kramer MP, Baumgarter L, et al. Honokiol: a non-adipogenic PPARgamma agonist from nature. Biochim Biophys Acta. 2013;1830:4813–910.1016/j.bbagen.2013.06.021Search in Google Scholar PubMed

[47] Brooijmans N, Kuntz ID. Molecular recognition and docking algorithms. Annu Rev Biophys Biomol Struct. 2003;32:335–73.10.1146/annurev.biophys.32.110601.142532Search in Google Scholar PubMed

[48] Bertoldo JB, Rodrigues T, Dunsmore L, Aprile FA, Marques MC, Rosado LA, et al. A water-bridged cysteine-cysteine redox regulation mechanism in bacterial protein tyrosine phosphatases. Chem. 2017;3:665–7710.1016/j.chempr.2017.07.009Search in Google Scholar PubMed

[49] Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, et al. Selective inhibition of BET bromodomains. Nature. 2010;468:1067–7310.1038/nature09504Search in Google Scholar PubMed

[50] Brik A, Wong CH. HIV-1 protease: mechanism and drug discovery. Org Biomol Chem. 2003;1:5–14.10.1039/b208248aSearch in Google Scholar PubMed

[51] Cappel D, Sherman W, Beuming T. Calculating water thermodynamics in the binding site of proteins - applications of WaterMap to drug discovery. Curr Top Med Chem. 2017;17:2586–98.10.2174/1568026617666170414141452Search in Google Scholar PubMed

[52] Ladbury JE. Just add water! The effect of water on the specificity of protein-ligand binding sites and its potential application to drug design. Chem Biol. 1996;3:973–80.10.1016/S1074-5521(96)90164-7Search in Google Scholar PubMed

[53] Totrov M, Abagyan R. Flexible ligand docking to multiple receptor conformations: a practical alternative. Curr Opin Struct Biol. 2008;18:178–84.10.1016/j.sbi.2008.01.004Search in Google Scholar PubMed

[54] Chen YZ, Zhi DG. Ligand-protein inverse docking and its potential use in the computer search of protein targets of a small molecule. Proteins. 2001;43:217–26.10.1002/1097-0134(20010501)43:2<217::AID-PROT1032>3.0.CO;2-GSearch in Google Scholar PubMed

[55] Do QT, Lamy C, Renimel I, Sauvan N, Andre P, Himbert F, et al. Reverse pharmacognosy: identifying biological properties for plants by means of their molecule constituents: application to meranzin. Planta Med. 2007;73:1235–4010.1055/s-2007-990216Search in Google Scholar PubMed

[56] Brown RD, Martin YC. The information content of 2D and 3D structural descriptors relevant to ligand-receptor binding. J Chem Inf Comp Sci. 1997;37:1–9.10.1021/ci960373cSearch in Google Scholar

[57] Keiser MJ, Roth BL, Armbruster BN, Ernsberger P, Irwin JJ, Shoichet BK, et al. Relating protein pharmacology by ligand chemistry. Nat Biotechnol. 2007;25:197–20610.1038/nbt1284Search in Google Scholar PubMed

[58] Bajusz D, Racz A, Heberger K. Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations? J Cheminf. 2015;7:20.10.1186/s13321-015-0069-3Search in Google Scholar

[59] Sheridan RP, Kearsley SK. Why do we need so many chemical similarity search methods? Drug Discov Today. 2002;7:903–11.10.1016/S1359-6446(02)02411-XSearch in Google Scholar PubMed

[60] Bender A, Jenkins JL, Scheiber J, Sukuru SC, Glick M, Davies JW. How similar are similarity searching methods? A principal component analysis of molecular descriptor space. J Chem Inf Model. 2009;49:108–1910.1021/ci800249sSearch in Google Scholar PubMed

[61] Sa MS, de Menezes MN, Krettli AU, Ribeiro IM, Tomassini TC, Ribeiro dos Santos R, et al. Antimalarial activity of physalins B, D, F, and G. J Nat Prod. 2011;74:2269–7210.1021/np200260fSearch in Google Scholar

[62] Poroikov V, Filimonov D, Lagunin A, Gloriozova T, Zakharov A. PASS: identification of probable targets and mechanisms of toxicity. SAR QSAR Environ Res. 2007;18:101–10.10.1080/10629360601054032Search in Google Scholar PubMed

[63] Lagunin A, Stepanchikova A, Filimonov D, Poroikov V. PASS: prediction of activity spectra for biologically active substances. Bioinformatics. 2000;16:747–8.10.1093/bioinformatics/16.8.747Search in Google Scholar PubMed

[64] Filimonov D, Poroikov V, Borodina Y, Gloriozova T. Chemical similarity assessment through multilevel neighborhoods of atoms: definition and comparison with the other descriptors. J Chem Inf Comp Sci. 1999;39:666–70.10.1021/ci980335oSearch in Google Scholar

[65] Lagunin A, Filimonov D, Poroikov V. Multi-targeted natural products evaluation based on biological activity prediction with PASS. Curr Pharm Des. 2010;16:1703–17.10.2174/138161210791164063Search in Google Scholar PubMed

[66] Zeng X, Zhang P, He W, Qin C, Chen S, Tao L, et al. NPASS: natural product activity and species source database for natural product research, discovery and tool development. Nucleic Acids Res. 2018;46:D1217–D122210.1093/nar/gkx1026Search in Google Scholar PubMed PubMed Central

[67] Butler KT, Davies DW, Cartwright H, Isayev O, Walsh A. Machine learning for molecular and materials science. Nature. 2018;559:547–55.10.1038/s41586-018-0337-2Search in Google Scholar PubMed

[68] Merk D, Friedrich L, Grisoni F, Schneider G. De novo design of bioactive small molecules by artificial intelligence. Mol Inf. 2018;37:1700153.10.1002/minf.201700153Search in Google Scholar PubMed PubMed Central

[69] Kirchmair J, Williamson MJ, Afzal AM, Tyzack JD, Choy AP, Howlett A, et al. FAst MEtabolizer (FAME): A rapid and accurate predictor of sites of metabolism in multiple species by endogenous enzymes. J Chem Inf Model. 2013;53:2896–90710.1021/ci400503sSearch in Google Scholar PubMed

[70] Tian S, Wang J, Li Y, Xu X, Hou T. Drug-likeness analysis of traditional Chinese medicines: prediction of drug-likeness using machine learning approaches. Mol Pharm. 2012;9:2875–86.10.1021/mp300198dSearch in Google Scholar PubMed

[71] Segler MH, Preuss M, Waller MP. Planning chemical syntheses with deep neural networks and symbolic AI. Nature. 2018;555:604–10.10.1038/nature25978Search in Google Scholar PubMed

[72] Mayr A, Klaumbauer G, Unterthiner T, Steijaert M, Wegner JK, Cuelemans H, et al. Large-scale comparison of machine learning methods for drug target prediction on ChEMBL. Chem Sci. 2018;9:5441–5110.1039/C8SC00148KSearch in Google Scholar PubMed

[73] Reutlinger M, Koch CP, Reker D, Todoroff N, Schneider P, Rodrigues T, et al. Chemically advanced template search (CATS) for scaffold-hopping and prospective target prediction for ‘orphan’ molecules. Mol Inf. 2013;32:133–810.1002/minf.201200141Search in Google Scholar PubMed PubMed Central

[74] Schneider P, Schneider G. Collection of bioactive reference compounds for focused library design. QSAR Comb Sci. 2003;22:713–8.10.1002/qsar.200330825Search in Google Scholar

[75] Rodrigues T, Reker D, Kunze J, Schneider P, Schneider G. Revealing the macromolecular targets of fragment-like natural products. Angew Chem Int Ed. 2015;54:10516–20.10.1002/anie.201504241Search in Google Scholar PubMed

[76] Reker D, Perna AM, Rodrigues T, Schneider P, Reutlinger M, Monch B, et al. Revealing the macromolecular targets of complex natural products. Nat Chem. 2014;6:1072–810.1038/nchem.2095Search in Google Scholar PubMed

[77] Schneider G, Reker D, Chen T, Hauenstein K, Schneider P, Altmann KH, et al. Deorphaning the macromolecular targets of the natural anticancer compound doliculide. Angew Chem Int Ed. 2016;55:12408–1110.1002/anie.201605707Search in Google Scholar PubMed

[78] Rodrigues T, Sieglitz F, Somovilla VJ, Cal PM, Galione A, Corzana F, et al. Unveiling (-)-englerin A as a modulator of L-type calcium channels. Angew Chem Int Ed. 2016;55:11077–8110.1002/anie.201604336Search in Google Scholar PubMed PubMed Central

[79] Schneider P, Schneider G. De-orphaning the marine natural product (+/-)-marinopyrrole A by computational target prediction and biochemical validation. Chem Commun. 2017;53:2272–4.10.1039/C6CC09693JSearch in Google Scholar

[80] Schneider P, Schneider G. A computational method for unveiling the target promiscuity of pharmacologically active compounds. Angew Chem Int Ed. 2017;56:11520–4.10.1002/anie.201706376Search in Google Scholar PubMed

[81] Rodrigues T, Werner M, Roth J, da Cruz EHG, Marques MC, Akkapeddi P, et al. Machine intelligence decrypts β-lapachone as an allosteric 5- lipoxygenase inhibitor. Chem Sci. 2018;9. DOI: 10.1039/C8SC02634CSearch in Google Scholar PubMed PubMed Central

[82] Robke L, Rodrigues T, Schroder P, Foley DJ, Bernardes GJL, Laraia L, et al. Discovery of 2,4-dimethoxypyridines as novel autophagy inhibitors. Tetrahedron. 2018;74:4531–7. DOI: 10.1016/j.tet.2018.1007.1021Search in Google Scholar

[83] Patridge E, Gareiss P, Kinch MS, Hoyer D. An analysis of FDA-approved drugs: natural products and their derivatives. Drug Discov Today. 2016;21:204–7.10.1016/j.drudis.2015.01.009Search in Google Scholar PubMed

[84] Wassermann AM, Lounkine E, Hoepfner D, King FJ, Studer C, Peltier JM, et al. Dark chemical matter as a promising starting point for drug lead discovery. Nat Chem Biol. 2015;11:958–6610.1038/nchembio.1936Search in Google Scholar PubMed